Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Thallion Pharmaceuticals Inc V.TLN



TSXV:TLN - Post by User

Post by Everswanon Jun 30, 2009 8:39pm
148 Views
Post# 16110027

Expecting Good GBM results.

Expecting Good GBM results.
- Well all gbm researchers agree that a Ras-inhibitor is probably the answer to GBM. The scientific litterature is unanimous on this point.

- Sarbasil is a similar drug to 4601 and has reported positive results at ASCO 2009

- There are numerous preclinical and PI compounds all following the same premises as 4601.

Overrall, 4601 is superior because it is derived from iteration. Decipher technology is a software design to find the best match , the best drug design.

CEllcarta technology is the best non clinical validation plateform and 4601 has passed that too.

I think we can all hope for a slam dunk!

Bullboard Posts